Tag Archives: Arcera Life Sciences

Health Care

Arcera Life Sciences and Fosun Pharma launch long-term collaboration framework

  • Strategic framework established for regional and global licensing, frontier technology incubation, and strategic collaboration in neurodegenerative diseases
  • Joint R&D aligned with China-UAE bilateral partnership and Abu Dhabi’s Healthcare Life Sciences Vision 2030

Abu Dhabi, United Arab Emirates and Shanghai, China, April 28, 2026 – Arcera Life Sciences (“Arcera”), a global life sciences company headquartered in Abu Dhabi, and Shanghai Fosun Pharmaceutical Group Co., Ltd. (“Fosun Pharma”), an innovation-driven global pharmaceutical and healthcare group, today announced the signing of a Memorandum of Understanding (MoU) to establish a long-term strategic collaboration focused on licensing, technology development, neuroscience innovation and value creation in the global life sciences sector.

The agreement was executed by Sunil Bhilotra, Chief Investment Officer of Arcera, and Xingli Wang, Co-President of Fosun Pharma, CEO of Innovative Medicines Division in Shanghai, China. The signing ceremony was witnessed by Qunbin Wang, Co-Chairman of Fosun International; Yuqing Chen, Chairman of Fosun Pharma; Isabel Afonso, Chief Executive Officer of Arcera; and Rafael Ferrer, SVP Corporate Development of Arcera.

Continue reading Arcera Life Sciences and Fosun Pharma launch long-term collaboration framework →
Health Care

Arcera Life Sciences Convenes Global Healthcare Leaders in Abu Dhabi to Accelerate AI-Powered Healthcare Transformation Across the Middle East and beyond

Held during the annual “UAE Innovates” month, which aims to reinforce the UAE’s position as an international beacon of innovation, Arcera’s ‘Catalyst: Collaborating to Turn AI Vision to Value’ forum at NYU Abu Dhabi highlighted the company’s focus on strengthening its AI capabilities to drive healthcare excellence and enhance experiences for patients and medical professionals.

Abu Dhabi, United Arab Emirates, February 4, 2026 – Arcera Life Sciences (“Arcera”), a global life sciences company headquartered in Abu Dhabi, today convened a distinguished gathering of global academic, government and industry leaders at New York University Abu Dhabi (NYU Abu Dhabi) to help shape how Artificial Intelligence can be applied responsibly and effectively to transform healthcare across the Middle East region and beyond .

Continue reading Arcera Life Sciences Convenes Global Healthcare Leaders in Abu Dhabi to Accelerate AI-Powered Healthcare Transformation Across the Middle East and beyond →